DogBreedCompass
← Back to breed profile

PRA-rcd3: Reading a Genetic Result for a Bichon Frise

Quick answer

What is rcd3?

A specific inherited retinal degeneration variant characterised in the Cardigan Welsh Corgi, not in the Bichon Frise.

A commercial panel can return a variant name for your Bichon that has never been shown to cause disease in Bichons. That is not a diagnosis, and it is not nothing either. It needs interpreting.

PRA-rcd3: Reading a Genetic Result for a Bichon Frise infographic

Owners who ran a mail-order DNA panel and got a result they cannot interpret, and breeders trying to work out which of the many available tests are worth paying for in this breed.

Important reminder

This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.

Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.

What this problem looks like

This page addresses a testing and interpretation problem rather than a disease. PRA-rcd3 is a named variant validated in a different breed, and it appears on Bichon reports because commercial panels test broadly rather than selectively. The practical task for an owner or breeder is deciding what a result means, whether it should change any decision, and what screening would actually be informative for this breed.

Common triggers

  • A broad direct-to-consumer DNA panel returning an unexpected variant
  • A breeder advertising a long list of genetic clearances
  • Research prompted by noticing a dog hesitating in dim light
  • A breed club or registry recommendation about eye testing
  • Comparing two puppies whose breeders test differently

Confusion about panel results is far more common than any of the variants tested. Broad panels covering many conditions have become inexpensive and widely marketed, and the number of owners receiving an unexplained carrier result greatly exceeds the number of dogs actually affected by the conditions listed. For Bichons specifically, no rcd3-associated retinal disease is documented.

Why this happens

Breed factors

The Bichon Frise is not a breed in which this variant has been characterised, and that is the central point. Where its documented traits are relevant is in what should be screened instead: cataracts sit on the breed's health list, making a clinical ophthalmic examination the high-value test. The breed's long lifespan of 14 to 15 years also means that whatever eye changes do occur have plenty of time to develop, which favours repeated examination over a single test at any age.

Environment factors

The commercial testing market shapes this problem. Panels are priced and marketed to test as many variants as possible regardless of breed relevance, and the reports rarely distinguish between a validated finding and an incidental one. Aggregated breed health pages then copy condition names across breeds without checking provenance, so a variant appears attached to a breed simply because a page listing it once existed.

What you can do at home (once it is not an emergency)

When to talk to your vet

Take any unexpected genetic result to your vet before acting on it. Book an eye examination if your dog hesitates in the dark, bumps into objects in dim light, or seems clumsy in unfamiliar surroundings. Seek same-day attention for sudden vision loss, a squinting or painful eye, obvious redness, or any change affecting one eye and not the other, since those signs indicate an active problem rather than a slow inherited degeneration and can threaten sight within hours.

At home, alongside your vet's plan

  • Before buying a panel, write down what decision each possible result would change; if the answer is none, the test is not needed.
  • Keep the full report rather than a summary screenshot, since interpretation depends on the exact variant and zygosity.
  • Ask a breeder which tests they run and, more usefully, why those particular ones for this breed.
  • Prioritise booking a clinical eye examination over adding more DNA variants to a panel.
  • Check your dog's night navigation in an unfamiliar place occasionally, which detects functional vision loss no panel would.

See all Bichon Frise health problems, which breeds are prone to progressive retinal atrophy pra rcd3, or the full Bichon Frise breed guide for temperament, exercise needs and ownership costs.

What to expect, and how you know it is working

Interpreting a result is a single conversation. A clinical eye examination is one appointment and gives an immediate answer about the eye's current state. For breeding programmes, meaningful screening means repeating that examination annually across a dog's breeding life rather than testing once.

You understand what your dog's result does and does not mean, you have not made a breeding or purchasing decision on the basis of an unvalidated finding, and your dog has had its eyes actually examined by someone qualified to look at them.

What a named variant test actually tells you

Understanding the limits of these tests is what turns a confusing result into a manageable one.

  • It tests for one specific change at one location in the genome. It does not screen the retina, and it does not detect other retinal diseases.
  • It was validated by studying affected and unaffected dogs within particular breeds. Its predictive value comes from that population, not from the DNA sequence alone.
  • Most of these variants are recessive, meaning a dog needs two copies to be affected. One copy makes a carrier, which matters for breeding and not for the dog's own health.
  • rcd3 in particular is associated with the Cardigan Welsh Corgi, where it was characterised. It is not a Bichon Frise variant.
  • A clear result on one variant test does not mean a dog will not develop retinal disease from some other cause.

What is genuinely worth screening in this breed

If your goal is to protect your dog's eyes or to breed responsibly, there are more useful places to put the money.

The Bichon Frise's documented eye concern is cataracts, which appears on the breed's list of common health issues alongside skin allergies, patellar luxation, bladder stones and dental disease. Cataracts are detected by looking at the eye, not by sequencing DNA, which makes a clinical eye examination by a veterinary ophthalmologist the single most valuable eye screening available for this breed.

For breeding stock, a repeated eye examination through adulthood is more informative than a one-off DNA panel, because it detects whatever is actually present rather than only the variants included on the panel.

The other genuinely relevant screening for a Bichon is a veterinary patella examination, since patellar luxation is documented in the breed and is straightforward and inexpensive to assess.

None of this means DNA testing is worthless. It means the question to ask before buying a panel is which of these results would change a decision you are actually making.

PRA-rcd3 and the Bichon Frise - what to screen instead
PRA-rcd3 and the Bichon Frise - what to screen instead

A carrier result and a breeding plan nearly abandoned

Hana had planned her Bichon bitch's first litter for a year. A week before the mating, a panel she had ordered out of thoroughness returned a carrier result for a named retinal variant she had never heard of. She cancelled the mating and spent a fortnight assuming she had a genetic problem in her line. Then she took the report to her vet. Her vet explained that the variant had been characterised in an unrelated breed, that a single copy would not affect the dog even in that breed, and that the more useful step was an ophthalmologist examination. That examination was clear. The litter went ahead the following season.

Key takeaway: An unexpected variant name is a prompt to ask a question, not an answer. Whether the variant has been validated in your breed is the first thing to establish, and it changes everything that follows.

Frequently asked questions

Does PRA-rcd3 affect Bichon Frises?

There is no established rcd3 form of retinal degeneration in this breed. The variant was characterised in the Cardigan Welsh Corgi. A result reported for a Bichon on a broad commercial panel should be discussed with a vet before it is treated as meaningful.

My panel says my dog is a carrier. Is it going to go blind?

For a recessive variant, a carrier has one copy and is not expected to be affected. Even that framing assumes the variant behaves in your breed the way it does in the breed where it was validated, which for an unvalidated breed is an assumption rather than a fact.

Should I stop breeding a carrier?

For a validated variant in an affected breed, the usual advice is that a carrier can be bred to a clear dog without producing affected puppies. For an unvalidated result in a breed where the variant is not established, the sensible step is a conversation with a vet or breed club rather than an immediate decision.

Are these consumer DNA panels accurate?

Laboratory accuracy for detecting a variant is generally good. The weakness is interpretation: panels frequently report variants across breeds where their significance is unknown, and the accompanying explanation rarely makes that limitation clear to the reader.

What eye test should I ask a Bichon breeder for?

A clinical eye examination by a veterinary ophthalmologist on both parents, ideally repeated in adulthood rather than performed once. Given that cataracts are documented in this breed, that examination is more relevant than any single DNA variant result.

Can a DNA test replace an eye examination?

No. DNA testing detects specific known variants. An eye examination detects what is actually happening in that dog's eyes, including conditions with no genetic test, conditions acquired rather than inherited, and early changes before any signs appear.

Quick answers

View more answers
Health

What is rcd3?

A specific inherited retinal degeneration variant characterised in the Cardigan Welsh Corgi, not in the Bichon Frise.

Health

Does a carrier result mean my dog is ill?

For a recessive variant, no. A carrier has one copy and is not expected to develop the condition itself.

Costs

Are broad DNA panels worth the money?

Only if a result would change a decision. Ask that question before buying, not after receiving a confusing report.

Health

What should I do with an unexpected result?

Bring the printout to your vet rather than acting on it. Interpretation depends on whether the variant is validated in your breed.

Living

How often should eyes be examined?

Annually for breeding stock, and at routine health checks for pet dogs, with prompt attention to any change in night vision.

Related DogBreedCompass guides

  • progressive retinal atrophy signs and managementThe clinical picture of retinal degeneration is covered on the general page.
  • cataracts in the Bichon FriseCataracts are this breed's documented eye concern and the priority for screening.
  • genetic testing and the Bichon FriseBroader genetic testing questions apply the same interpretation rules.
  • patellar luxation screeningPatella examination is the other genuinely relevant screening for this breed.
  • Bichon Frise breed guideBuyers assessing breeder claims want the full breed profile.

Bring the right questions to the vet

A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.

You get: Vet visit prep sheet

No spam. One-click unsubscribe. See our privacy policy.

Preview page 1 before you decide.

Related guides